10 Can Sino (China) Funding: N/A Clinical progress: Phase I/II: Phase II results showed that after a single injection, most subjects stimulated a significant immune response. Phase III: 40,000 volunteers will be recruited for trials in Russia, Brazil, Chile, and the Philippines. This is China's first COVID-19 vaccine to enter clinical trials and the first domestic COVID-19 vaccine to be approved for military special needs. The validity period is one year. This adenovirus vector vaccine, developed in cooperation with the team of Cansino and Academician Chen Wei, has completed a phase II clinical study in June. The research results show that the vaccine can induce the human body to produce specific antibodies and has good effectiveness and safety. The company is currently preparing to start phase III clinical trials with many countries. It plans to recruit 5,000 healthy volunteers over 18 years of age in three major cities in Saudi Arabia, Riyadh, Dammam and Mecca. It is estimated that 100 to 200 million doses of vaccine can be produced by early 2021.
The Centers for Disease Control and Prevention is telling state health officials to be ready to distribute a coronavirus vaccine to health-care workers and other high-priority groups as soon as Nov. 1, heightening fears that the agency is under pressure to approve a vaccine before Election Day. Some scientists warn that granting emergency authorization to a vaccine before clinical trials are complete could pose safety dangers and inflame anti-vaccination sentiment — but others say that doing so could save thousands of lives.
Van Bus Stop wrong prediction. He said going up but later slump. Where got? This stay a bit upward.
He said look carefully at warrant. How to look? Bcos mother up, warrant of course up lah. Likewise if mother down, of course warrant will go down also. So what to look for in warrant??? Strange Van Bus Stop
Secret boy.. don’t laugh at the inevitable..u suka x suka, vaccine is coming. Best u can do now is join the ride before it take off. U wan number, assume each vaccine is rm 100, your revenue already rm 3.2 billion.. normal flu jab already rm 150 in private clinic, you think covid vaccine can go lower than that?
hi barbie u want to go for a ride? Sure Ken hop in then! I'm a Barbie girl in a barbie world made if plastic it's fantastic u can brush my hair undress me everywhere
Buy the Anak I mentioned because they give u highest percentage gain Lo..... Double. Triple your money... I never touch mother... Too wrinkled move 20 sen only small percentage... I bought supermax c78, 79, 8l in April made several fold, of course I used different id to promote then, sweetheart ...
Run la ! You follow stockraider you go Holland ! Vaccine out also not Malaysia turn first atleast another half a year ! this counter qr will not sustain for atleast 3-4 quarters !
Share price will soon kaput ! Take profit and run !
Solution already no momentum and is going down anytime soon, those who still holding and feel difficulty to cut loss at this time - -- -- will loss all eventually.
the company has no expertise, no facilities, no experience, no license/permit , no distribution contract from government , and only with a paper of MoU ( some more is valid 1 year ) can trap you all, don you feel sad ? pls study first before enter to share trading.
Need 1 dose per year la, normal flu vaccine also take once per year.. covid is like flu, here to stay long term, 3.2 billion revenue per year!! Conservative estimation.
Msia will buy from different companies la... Bintai, Solution, Hwgb, duopharma, pharmaniaga, etc... we don’t want to be held hostage by one company la...
CANSINO WITH SOLUTION AS DISTRIBUTOR WILL BE THE 1st COVID19 VACCINE OFFICIAL SELLER IN MALAYSIA MAH...!!
IN ORDER WORDS CANSINO VACCINE WILL BE THE 1ST COVID19 VACCINE IN MSIA SELLING TO THE PUBLIC, KKM THE GOVT AND AS WELL TO PRIVATE HOSPITAL AND CLINICS (FOR THE PRIVATE HOSPITALS & CLINICS} LOH...!!
THIS MEAN CANSINO IS WINNING THE VACCINE RACE IN MSIA LOH...!!
IT IS EXPECTED CANSINO COVID19 VACCINE, WILL BE THE 1ST AVAILABLE IN MSIA FROM OCT TO NOV 2020 MAH....!!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
clementw
31 posts
Posted by clementw > 2020-09-03 21:02 | Report Abuse
http://www.pharmcube.com/news/article/5367?index=news
10 康希诺(中国)资金:N/A
临床进展:Phase I/II:II期结果显示,单针免疫后,绝大多数受试者体内激发了显著的免疫反应。Phase III:即将在俄罗斯、巴西、智利和菲律宾招募40000名志愿者进行试验这是中国首个进入临床试验的新冠疫苗,也是国内首个获得军队特需药品批件的新冠疫苗,有效期一年。这款由康希诺与陈薇院士团队合作开发的腺病毒载体疫苗,已在6月份完成了II期临床研究,研究结果显示,该疫苗能够诱导人体产生特异性抗体,具有较好的有效性和安全性。目前该公司正在准备与多国携手启动III期临床试验,拟计划在沙特的利雅得、达曼和麦加3个主要城市招募5000名18岁以上健康志愿者进行试验。预计到2021年初可生产1~2亿剂疫苗。
10 Can Sino (China) Funding: N/A
Clinical progress: Phase I/II: Phase II results showed that after a single injection, most subjects stimulated a significant immune response. Phase III: 40,000 volunteers will be recruited for trials in Russia, Brazil, Chile, and the Philippines. This is China's first COVID-19 vaccine to enter clinical trials and the first domestic COVID-19 vaccine to be approved for military special needs. The validity period is one year. This adenovirus vector vaccine, developed in cooperation with the team of Cansino and Academician Chen Wei, has completed a phase II clinical study in June. The research results show that the vaccine can induce the human body to produce specific antibodies and has good effectiveness and safety. The company is currently preparing to start phase III clinical trials with many countries. It plans to recruit 5,000 healthy volunteers over 18 years of age in three major cities in Saudi Arabia, Riyadh, Dammam and Mecca. It is estimated that 100 to 200 million doses of vaccine can be produced by early 2021.